24 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
Morgan Stanley (MS) Mulling to Offer Spot Bitcoin ETFs https://www.zacks.com/stock/news/2234147/morgan-stanley-ms-mulling-to-offer-spot-bitcoin-etfs?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234147 Feb 29, 2024 - Morgan Stanley (MS) is exploring the addition of spot bitcoin ETF offerings to its customers on its large brokerage platform.
Morgan Stanley (MS) Expands in UAE With Office in Abu Dhabi https://www.zacks.com/stock/news/2234547/morgan-stanley-ms-expands-in-uae-with-office-in-abu-dhabi?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234547 Mar 01, 2024 - Morgan Stanley (MS) establishes an office in Abu Dhabi to expand its footprint in the Middle East. The move is in line with its efforts to gain business opportunities from the capital markets in the region.
Contineum Therapeutics Seeks $150 Million IPO For MS Treatments https://seekingalpha.com/article/4679126-contineum-therapeutics-seeks-150-million-ipo-for-ms-treatments?source=feed_tag_ipo_analysis Mar 19, 2024 - Contineum Therapeutics plans to raise $150 million through an IPO for developing advanced medical treatments, with strong institutional support and a key...
Top Stock Reports for Disney, Morgan Stanley & Stryker https://www.zacks.com/commentary/2244021/top-stock-reports-for-disney-morgan-stanley-stryker?cid=CS-ZC-FT-research_daily-2244021 Mar 21, 2024 - Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Morgan Stanley (MS) and Stryker Corporation (SYK).
Morgan Stanley (MS) Declines More Than Market: Some Information for Investors https://www.zacks.com/stock/news/2245173/morgan-stanley-ms-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2245173 Mar 22, 2024 - In the most recent trading session, Morgan Stanley (MS) closed at $91.95, indicating a -1.55% shift from the previous trading day.
Markets Await PCE/Core-PCE Inflation Data https://www.zacks.com/stock/news/2245569/markets-await-pce-core-pce-inflation-data?cid=CS-ZC-FT-economic_highlights-2245569 Mar 25, 2024 - Markets Await PCE/Core-PCE Inflation Data
Will Morgan Stanley (MS) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2252141/will-morgan-stanley-ms-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2252141 Apr 08, 2024 - Morgan Stanley (MS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Ahead of Morgan Stanley (MS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics https://www.zacks.com/stock/news/2253844/ahead-of-morgan-stanley-ms-q1-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2253844 Apr 11, 2024 - Beyond analysts' top -and-bottom-line estimates for Morgan Stanley (MS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Clene stock rallies 52% post-market on MS drug data https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
Are You Looking for a High-Growth Dividend Stock? https://www.zacks.com/stock/news/2259447/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2259447 Apr 22, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes? Let's find out.

Pages: 123

Page 1>